Pain is a common complication of COVID-19 infection, during the illness and afterwards. Click through this summary of new data on acute pain and risk for persistent pain from COVID-19.
A common complication of coronavirus disease 2019 (COVID-19) that merits particular vigilance from doctors—when their patients have it and after—is pain, according to the authors of a recent review in Pain Reports. In it, they summarize incidences of acute pain during COVID-19, disorders accompanying COVID-19 that increase the risk of persistent pain, and the implications for patients who have chronic pain.
Key points from the Pain Reports article are highlighted in the slides below.
Cebranopadol Achieves Positive Phase 3 Results for Treatment of Moderate-to-Severe Acute Pain
January 22nd 2025Cebranopadol, an investigational oral dual-NMR agonist, satisfied the primary endpoint of statistically significant reduction in pain intensity compared to placebo following abdominoplasty surgery.